[HTML][HTML] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - Frontiers in pharmacology, 2013 - frontiersin.org
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
Mechanisms and insights into drug resistance in cancer.
H Zahreddine, KL Borden - Frontiers in Pharmacology, 2013 - europepmc.org
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
[PDF][PDF] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - scienceopen.com
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
[PDF][PDF] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - core.ac.uk
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
[PDF][PDF] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - 2013 - Citeseer
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
[HTML][HTML] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - Frontiers in Pharmacology, 2013 - ncbi.nlm.nih.gov
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
[PDF][PDF] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - academia.edu
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - Frontiers in pharmacology, 2013 - pubmed.ncbi.nlm.nih.gov
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
[引用][C] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - Frontiers in Pharmacology, 2013 - cir.nii.ac.jp
[PDF][PDF] Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden - researchgate.net
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …